Xeris Biopharma Holdings Inc (XERS)
3.225
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
3.23
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Gross Profit Margin (Quarterly): 83.79% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 83.79% |
| March 31, 2024 | 85.31% |
| December 31, 2023 | 82.95% |
| September 30, 2023 | 83.03% |
| June 30, 2023 | 80.12% |
| March 31, 2023 | 83.98% |
| December 31, 2022 | 81.02% |
| September 30, 2022 | 82.30% |
| June 30, 2022 | 80.99% |
| March 31, 2022 | 71.58% |
| December 31, 2021 | 77.19% |
| September 30, 2021 | 70.89% |
| June 30, 2021 | 62.01% |
| March 31, 2021 | 77.72% |
| December 31, 2020 | 53.77% |
| Date | Value |
|---|---|
| September 30, 2020 | 69.89% |
| June 30, 2020 | 35.92% |
| March 31, 2020 | -6.80% |
| December 31, 2019 | 14.00% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 84.03% |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | 99.29% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-6.80%
Minimum
Mar 2020
85.31%
Maximum
Mar 2024
66.82%
Average
77.72%
Median
Mar 2021
Gross Profit Margin (Quarterly) Benchmarks
| Zoetis Inc | 71.71% |
| Zevra Therapeutics Inc | 19.69% |
| NovaBay Pharmaceuticals Inc | 66.33% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -18.08% |
| Return on Invested Capital | -29.43% |
| Profit Margin (Quarterly) | -31.22% |
| Operating Margin (Quarterly) | -17.03% |
| Return on Net Operating Assets | -24.77% |